Member Info for potnak

Correct, Lucan. Can't give news, if there isn't any to give and bad news, is news. So it's good news that we haven't had any news. :-)

Afham. Tim has actually stated that when asked about the US lupus data. He said if it was bad, we would have to tell you. Pretty sure its the same across all compounds.

We are kidding ourselves, in a way. There has been some fantastic research done and posted here. Reading it makes me feel confident we have something. But we have to be careful not to push that expectation on the company. The research is for our benefit. It isn't and may not ever be the path the company is taking. I've always thought SAR are one of the better AIM companies regarding news flow. Could we have jumped on the Covid bandwagon, absolutely but it would have given the LTH anything. It would have just fed the AIM traders and added to the general unregulated dark side of AIM. When our Covid news comes, and it will. It will be actual news, much better for the long term investor.

Krone - the lack of grant news makes me think we are ready to partner up an we don't need a grant. It would also explain the silence. Remember when Tim said "no news is good news"? IMO we are there again.

Ha ha. There is a reason psychology students frequent these boards. You can see how negative and positive sentiment spreads on very little evidence.

I'm in agreement, RMM. I'm comfortable with my investment here, a lot more comfortable than I have been for a year or so. I do check in here throughout the day but can take it or leave it. I'm not stressing on the SP intra day stuff. It's all good. I honestly think significant value is coming our way. Significant value for me is anything from 5p to 50p.

It maybe the "calm before the storm" but i'm expecting news on TYK2 because based on Tim's own forecast, we should be getting imminent news in the next month or so. Ironically, I think the Covid aspect might extend that deadline. We shall see.

If this goes the way we want it too. I'm off to a health retreat somewhere hot. Long ****tails and massages everyday. :-)

I know what you mean elcap. I haven't put weight on because I'm still getting out for a run but working from home isn't good on my body. I'm aching and creaking everywhere.

A couple have been named. SAR won't be in there, yet! We would have had an RNS. https://www.gov.uk/government/news/covid-19-treatments-could-be-fast-tracked-through-new-national-clinical-trial-initiative

I'm surprised we don't already know. Now thinking an RNS will say we have partnered with someone.

It's this.

Shares LogoMenu

ArchivesMagazine - 14 Jun 2018
Understanding the different types of stock market announcements
Do you know the different types of RNS news and how each one is relevant?
14 June 2018|Education
Among the benefits of investing in a stock market-listed company is transparency. All London-listed firms are required to report important bits of information which could have an impact on their share price in a timely fashion.

If you’ve ever wondered what the different types of announcements mean, read on as we’ll explain the importance of the main ones.

Most companies communicate with the market through the Regulatory News Service (better known as RNS) – a service owned by the London Stock Exchange (LSE).

Close to 300,000 announcements are processed by RNS each year and more than 70% of all regulatory and potentially price-sensitive UK company announcements originate from RNS. Alternative distributors of regulatory news include PRNewswire, GlobeNewswire and BusinessWire.

Rather than go to each distributor’s own website to find the announcements, the easiest way is to use a specialist financial data website such as Sharesmagazine.co.uk (click the ‘Market News’ tab). Here you find all the main announcements in a single place.

The bulk of the announcements will be made at 7am which gives investors one hour to digest the news before the UK stock market opens. However, further announcements do trickle out throughout the day, albeit you’ll find that very few of these will relate to financial results or trading updates.

WHAT HAS TO BE DISCLOSED AND WHEN?

When, why and how companies update the market is governed by a series of rules from the Financial Conduct Authority, the London Stock Exchange and European Union.

The central point is a company must notify through an approved regulatory information service like RNS any inside information relating to the company.

For an item of news to be classed as ‘inside information’ it must meet the following criteria:

- Be of a precise nature and specific to the company

- Not be generally available

- Be likely to have a significant effect on the price of the shares (be price sensitive) if it were generally available

Price sensitive is generally deemed a swing of 10%. Being awarded a grant is price sensitive IMO.

Show me your evidence first.

I have thought the same thing, Krone. Surely poc is done at the preclinical stage anyway?so no need to inform the market. I find the whole TYK2 /Covid thing bizarre. The company hints our compounds are promising but then nothing. Other companies put Covid news out with the vaguest of links to Covid. I keep trying to think of different angles here but always end up back at ongoing discussions that started before Covid.

Doesn't matter where we look. The deal is done. We can't change it. We won't have to wait too long to find out who it is\was. Hopefully they will crack the solubility issues and we'll get our £900k and find out what they are going to be doing with it.

RMM, yes. TYK2 is the main focus but Aurora FLT3 could be a dark horse and come out of nowhere.

Just to add to my post. If the mystery pharma does manage to solve the solubility issues of Aurora. I think they will just make an offer to take it off our hands without saying what they will develop it for.

I think the market sentiment on Covid is due the amount of companies entering the race. A lot of them are clearly cynical attempts to generate a bit of excitement on their own stagnant drugs. No one has a magic bullet yet. So who do you back?Things will really hot up when the first round of data is read out, sometime in the summer. No efficacy in some will push the the price up in others. On China. I'm here to make money. I always say there is no moral high ground to take when you are investing, someone has to lose for me to win. Having said that, the China thing makes me feel uneasy and I'm definitely not a conspiracy theorist. If the Aurora thing was talked about months ago and it didn't work out but news still got out. Tim's reputation would be ruined in the US pharma world.

Yes, Stoney. Add all that to the fact that TYK2 was on track to go into clinics this year anyway and we have our own storm brewing. I still don't think Aurora deal was originally for Covid. Tim said talks had been going on for 6 months. The RNS clearly states for cancer. We're into conspiracy theory territory if this mystery Chinese pharma had identified a FLT3 link back in November 2019. Wouldn't be great PR if it was proved to be true. "UK biotech talking to China about Covid treatments in November 2019" wouldn't be a good headline. Not saying they won't be looking at it now though.

It does feel like a news kind of day.